15 April, 2025

Colon AiQ: The Scientific, Simple, and Reliable Answer to Colorectal Cancer | CNN Greece

A molecular test, simple and reliable, is the modern scientific answer for colorectal cancer screening.

Nikos Tsoulos: “Prevention is a personal responsibility”

In an in-depth discussion with CNN Greece, Dr. Nikos Tsoulos, Biochemist – Molecular Biologist and CEO of IQ Genomix, spoke about the importance of colorectal cancer prevention and the reasons why people often neglect preventive screening.

Fear of Colonoscopy and Lack of Access

Nikos Tsoulos addressed the reasons that prevent people from visiting their doctor in time:

Fear and aversion to the colonoscopy procedure are usually the reasons we delay seeing our doctor,” he points out, adding that limited access to healthcare services is also a major barrier for many individuals.

Prevention Is a Personal Responsibility

Beyond technological advancements and new scientific solutions, Dr. Tsoulos delivered a clear message about the attitude each of us should have toward our health:

The only weapon we have is prevention, which does not concern the doctor, the hospital, or the healthcare system — it concerns each and every one of us,” he stated.
“We now have an active way to prevent cancer. We can detect colorectal cancer at an early stage, and when caught early, it is largely curable.”

His statement reflects the need for a cultural shift in how we approach prevention.

The Contribution of Science: Colon AiQ

Through this interview, the significance of applied science in the service of prevention was highlighted. As he explains, Colon AiQ is a test that addresses patients’ fears, as it is simple, blood-based, non-invasive, and capable of detecting precancerous lesions.

The Future of Diagnosis

Dr. Tsoulos concluded with an optimistic outlook on the future, stating that IQ Genomix is planning to launch new diagnostic tests by the end of 2025, supported by artificial intelligence, offering citizens even more options for cancer prevention.

Δείτε εδώ ολόκληρη τη συνέντευξη: